Recurrent ifosfamide-induced hyponatraemia [4]

European Journal of Cancer

Volumn 33, Issue 14, 1997, Pages 2438-2439

  Kirch, C ^a   Gachot, B ^a   Germann, N ^a   Blot, F ^a   Nitenberg, G ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE;

ADULT; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LETTER; NEUROBLASTOMA; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

EID: 0031415118     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00329-8     Document Type: Article

References (7)

1. Robertson GL, Berl T. Pathophysiology of water metabolism. In Brenner BM, ed. The Kidney , Vol. 1. Philadelphia, PA, WB Saunders Company, 1996, 873–928.
2. BMJ Cantwell M Idle MJ Millward G Hall MJ Lind Encephalopathy with hyponatraemia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusion Ann Oncol 1 1990 1232
3. S Culine M Ghosn JP Droz Inappropriate antidiuretic hormone secretion induced by ifosfamide Eur J Cancer 26 1990 922
4. R Izquierdo M Leinung Hyponatremia secondary to administration of ifosfamide Eur J Cancer 29A 1993 2072 2073
5. M Zalupski LH Baker Ifosfamide J Natl Cancer Inst 80 1988 556 566
6. Myers SL, Hardy DA, Wiebe CB, et al. Olfactory neuroblastoma invading the oral cavity in a patient with inappropriate ADH secretion. Oral Surg Oral Med Oral Pathol 1994, 77 , 645–650.
7. Pratt CB, Douglass EC, Kovnar EH, et al. A phase I study of ifosfamide given on alternate days to treat children with brain tumors. Cancer 1993, 71 , 3666–3669.